These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6295937)

  • 1. Carcinogenesis as a multistage process--experimental evidence.
    Weinstein IB
    IARC Sci Publ; 1982; (39):9-25. PubMed ID: 6295937
    [No Abstract]   [Full Text] [Related]  

  • 2. Epidermal growth factor receptors interact with transforming growth factors produced by certain human tumor cells and are distinct from specific membrane receptors for phorbol and ingenol esters.
    Todaro GJ; De Larco JE; Shoyab M
    Carcinog Compr Surv; 1982; 7():443-62. PubMed ID: 6279294
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of teleocidin and the phorbol ester tumor promoters on cell transformation, differentiation, and phospholipid metabolism.
    Fisher PB; Miranda AF; Mufson RA; Weinstein LS; Fujiki H; Sugimura T; Weinstein IB
    Cancer Res; 1982 Jul; 42(7):2829-35. PubMed ID: 6805947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factors. Isolation, characterization, and interaction with cellular receptors.
    Massagué J
    Prog Med Virol; 1985; 32():142-58. PubMed ID: 2991987
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of epidermal growth factor in carcinogenesis.
    Stoscheck CM; King LE
    Cancer Res; 1986 Mar; 46(3):1030-7. PubMed ID: 3002608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the epidermal growth factor receptor and transforming growth factor alpha in mouse skin carcinogenesis.
    DiGiovanni J; Rho O; Xian W; Beltràn L
    Prog Clin Biol Res; 1994; 387():113-38. PubMed ID: 7972243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered subcellular distribution of protein kinase C (a phorbol ester receptor). Possible role in tumor promotion and the regulation of cell growth: relationship to changes in adenylate cyclase activity.
    Anderson WB; Estival A; Tapiovaara H; Gopalakrishna R
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1985; 19():287-306. PubMed ID: 2988301
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative effects of aplysiatoxin, debromoaplysiatoxin, and teleocidin on receptor binding and phospholipid metabolism.
    Horowitz AD; Fujiki H; Weinstein IB; Jeffrey A; Okin E; Moore RE; Sugimura T
    Cancer Res; 1983 Apr; 43(4):1529-35. PubMed ID: 6299522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new tumor-promoting agent, dihydroteleocidin B, markedly enhances chemically induced malignant cell transformation.
    Hirakawa T; Kakunaga T; Fujiki H; Sugimura T
    Science; 1982 Apr; 216(4545):527-9. PubMed ID: 6280280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Teleocidin: new naturally occurring tumor promoter.
    Sugimura T; Fujiki H; Mori M; Nakayasu M; Terada M; Umezawa K; Moore RE
    Carcinog Compr Surv; 1982; 7():69-73. PubMed ID: 6802497
    [No Abstract]   [Full Text] [Related]  

  • 11. Aggregation of human lymphoblastoid cells by tumor-promoting phorbol esters and dihydroteleocidin B.
    Hoshino H; Miwa M; Fujiki H; Sugimura T
    Biochem Biophys Res Commun; 1980 Jul; 95(2):842-8. PubMed ID: 6251823
    [No Abstract]   [Full Text] [Related]  

  • 12. Stimulation of DNA synthesis in murine fibroblasts by the tumour promoter teleocidin: relationship to phorbol esters and vasopressin.
    Collins M; Rozengurt E
    Biochem Biophys Res Commun; 1982 Feb; 104(4):1159-66. PubMed ID: 6803796
    [No Abstract]   [Full Text] [Related]  

  • 13. Interactions in the natural history of aging and carcinogenesis.
    Pitot HC
    Fed Proc; 1978 Dec; 37(14):2841-7. PubMed ID: 569079
    [No Abstract]   [Full Text] [Related]  

  • 14. [Oncofactors (transforming growth factors)].
    Golubev AG; Dil'man VM
    Vopr Onkol; 1983; 29(5):86-98. PubMed ID: 6305035
    [No Abstract]   [Full Text] [Related]  

  • 15. Protein kinase C in signal transduction and carcinogenesis.
    Blumberg PM; Acs G; Areces LB; Kazanietz MG; Lewin NE; Szallasi Z
    Prog Clin Biol Res; 1994; 387():3-19. PubMed ID: 7972255
    [No Abstract]   [Full Text] [Related]  

  • 16. [Oncogens and carcinogenesis].
    Ageenko AI; Erkhov VS
    Vopr Onkol; 1982; 28(10):114-20. PubMed ID: 6755897
    [No Abstract]   [Full Text] [Related]  

  • 17. Results and speculations related to recent studies on mechanisms of tumor promotion.
    Weinstein IB; Horowitz AD; Mufson RA; Fisher PB; Ivanovic V; Greenebaum E
    Carcinog Compr Surv; 1982; 7():599-616. PubMed ID: 7039835
    [No Abstract]   [Full Text] [Related]  

  • 18. Cutaneous chemical carcinogenesis.
    Yuspa SH
    J Am Acad Dermatol; 1986 Nov; 15(5 Pt 1):1031-44. PubMed ID: 3537025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial cellular targets and eventual genomic changes in multistage carcinogenesis.
    Weinstein IB; Gattoni-Celli S; Kirschmeier P; Lambert M; Hsiao W; Backer J; Jeffrey A
    IARC Sci Publ; 1984; (56):277-97. PubMed ID: 6549538
    [No Abstract]   [Full Text] [Related]  

  • 20. Neoplastic transformation in cell cultures: in-vitro/in-vivo correlations.
    Bertram JS
    IARC Sci Publ; 1985; 67():77-91. PubMed ID: 3913645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.